Article Details

GSK, CureVac extend collaboration into €1.4bn licensing agreement

Retrieved on: 2024-07-04 15:48:41

Tags for this article:

Click the tags to see associated articles and topics

GSK, CureVac extend collaboration into €1.4bn licensing agreement. View article details on hiswai:

Excerpt

... mRNA development activities ... The two vaccine makers have been working together since 2020 to develop mRNA-based vaccines for infectious diseases, ...

Article found on: www.worldpharmaceuticals.net

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up